Breaking News

Thermo Fisher Expands GMP Lab Services with Mycoplasma and Biosafety Testing

Aims to provide lab customers a comprehensive solution to help ensure safe medicines for patients.

Author Image

By: Charlie Sternberg

Associate Editor

The PPD clinical research business of Thermo Fisher Scientific Inc. is adding mycoplasma and additional biosafety testing capabilities to its expanding portfolio of services at its good manufacturing practices (GMP) lab in Middleton, Wisconsin.   This new service, offered by the analytical testing service of the clinical research business, ensures biopharmaceutical products are free of contaminants, helping customers deliver safe medicines for patients.   “The continuing expansion of our GMP...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters